DpRx Corporation offers low-cost license agreements that make justification of this business opportunity very easy to accommodate. A license agreement is based on monthly license charges for a fixed duration. The longer the duration of the license, the lower the unit rates.

License arrangements contain two components – flat maintenance plus a charge per transaction. License durations are provided in one-year increments. 8% reductions per year are offered after the first year. (E.g. a three-year license will have a rate discount of 16%.)

The transaction fee for each transaction is usually established at much less than 1% of the average ingredient cost of the drugs dispensed.

DpRx is not considering direct sale of the software at this time. Options for application of prior license fees shall be included in license agreements when sales prices are established after two years or no later than January 2008.

Joint Venture Potential.

DpRx will consider participation in a Joint Venture with a local business and entrepreneurs whereby the license valuation will be DpRx’s contribution to the venture capitalization.

The operating expense to be considered by interested parties to this PBM opportunity should include Facilities (approximately 500 square feet); staff of at least two personnel; computer hardware (approximately US$12,000) and furniture and office expendables.

Marketing and sales expense will be dependent on the time contribution of the venture principals.